Evrysdi 0.75 mg (Risdiplam POWDER FOR SOLUTION) 0.75 MG

EVRYSDI 0.75 MG is a powder for oral solution containing risdiplam, used for managing certain neuromuscular conditions. This medication is designed to support muscle function and mobility.

Strength

0.75 MG

Manufacturer / TM Owner

HOFFMANN-LA ROCHE LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

EVRYSDI 0.75 MG is primarily used for the treatment of spinal muscular atrophy (SMA), a condition that affects muscle strength and function. Risdiplam, the active ingredient, works by increasing the production of a protein essential for muscle health. This medication is often prescribed to improve motor function and overall quality of life in patients with SMA.

Side Effects

Common effects of EVRYSDI 0.75 MG may include improvements in muscle strength and mobility. Some users may experience side effects such as fatigue, diarrhea, or upper respiratory tract infections. It's important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Precautions & Warnings

EVRYSDI 0.75 MG should be handled with care, ensuring proper storage and preparation as directed. It is essential to follow the prescribed dosage and administration instructions to minimize potential risks. Always inform healthcare providers about any existing medical conditions or other medications being taken.

Avoid Interactions

EVRYSDI 0.75 MG may interact with certain medications, including those that affect liver enzymes. It is advisable to avoid alcohol while using this medication, as it may exacerbate side effects. Always consult a healthcare provider before starting or stopping any medications while on EVRYSDI.

Frequently Asked Questions

EVRYSDI 0.75 MG is used to manage spinal muscular atrophy (SMA), a condition that affects muscle strength and function.

EVRYSDI 0.75 MG is a powder for oral solution, typically mixed with water and taken as directed by a healthcare provider.

Common side effects may include fatigue, diarrhea, and upper respiratory tract infections. Always consult a healthcare provider for personalized advice.

EVRYSDI 0.75 MG may interact with certain medications, so it's important to consult a healthcare provider before combining it with other treatments.

Long-term safety should be discussed with a healthcare provider, who can assess individual health conditions and potential risks.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.